Matching Adjusted Indirect Comparison (MAIC) Analysis For Ponatinib Vs Bosutinib In Third-Line Chronic Phase Chronic Myeloid Leukemia (CP-CML)
Nov 1, 2016, 00:00
10.1016/j.jval.2016.09.1328
https://www.valueinhealthjournal.com/article/S1098-3015(16)32694-8/fulltext
Title :
Matching Adjusted Indirect Comparison (MAIC) Analysis For Ponatinib Vs Bosutinib In Third-Line Chronic Phase Chronic Myeloid Leukemia (CP-CML)
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(16)32694-8&doi=10.1016/j.jval.2016.09.1328
First page :
A577
Section Title :
Disease-Specific Studies
Open access? :
No
Section Order :
1250